Related Experiment Video
Updated: Jul 11, 2026
11:04
An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023
[Photodynamic therapy in localised prostate cancer].
M Ramírez Backhaus1, M Trassierra Villa, C D Vera Donoso
1Servicio de Urología, Hospital Universitario La Fe, Valencia. ramirezbackhaus@yahoo.es
Actas Urologicas Espanolas
|September 28, 2007
Summary
Photodynamic therapy uses light and a photosensitizing drug to treat localized prostate cancer by destroying cancer cells. This promising technique offers a safe, repeatable treatment option with minimal side effects.
Area of Science:
- Oncology
- Biochemistry
- Medical Physics
Context:
- Photodynamic therapy (PDT) is emerging as a viable treatment for localized prostate cancer.
- Recent advancements have refined PDT techniques for improved therapeutic outcomes.
- Clinical trials are actively investigating PDT in various treatment scenarios.
Purpose:
- To review the principles and applications of photodynamic therapy in prostate cancer treatment.
- To highlight the safety profile and repeatability of PDT.
- To assess the future potential of PDT as a standard oncological therapy.
Summary:
- Photodynamic therapy involves activating a photosensitizing agent with specific light wavelengths in the presence of oxygen.
- This process generates reactive oxygen species, leading to targeted tissue necrosis, specifically in cancerous cells.
- PDT is being explored in clinical trials for organ-confined prostate cancer as both a primary and salvage therapy.
Impact:
- PDT demonstrates a favorable safety profile, with no risk of cancer dissemination or cumulative toxicity.
- The technique is repeatable and can be applied to previously irradiated tissues, offering flexibility in patient management.
- Photodynamic therapy is poised to become a significant therapeutic option for prostate cancer patients in the near future.
